Six problems with pharma-funded bioethics
- 25 February 2004
- journal article
- Published by Elsevier in Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences
- Vol. 35 (1) , 125-129
- https://doi.org/10.1016/j.shpsc.2003.12.008
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Unhealthy spinBMJ, 2003
- Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applicationsBMJ, 2003
- Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewBMJ, 2003
- Alosetron: a case study in regulatory capture, or a victory for patients' rights?BMJ, 2002
- A View from the Fourth EstateHastings Center Report, 2002
- Nigerians to sue US drug company over meningitis treatmentBMJ, 2001
- A physician survey of the effect of drug sample availability on physicians’ behaviorJournal of General Internal Medicine, 2000
- Physicians, pharmaceutical sales representatives, and the cost of prescribingArchives of Family Medicine, 1996
- Physicians' Behavior and Their Interactions With Drug CompaniesJAMA, 1994
- Scientific versus commercial sources of influence on the prescribing behavior of physiciansThe American Journal of Medicine, 1982